Skip to main content

New Frontier Data to Acquire the Medical Cannabis Businesses of Skylight Health Group Inc.

Written by Customer Service on . Posted in Mergers And Acquisitions.

New Frontier Data becomes the largest centralized source of U.S. medical cannabis patient data

Washington, Oct. 29, 2021 (GLOBE NEWSWIRE) — New Frontier Data (https://newfrontierdata.com), the premier data, analytics and technology firm specializing in the cannabis industry worldwide, has executed an Asset Purchase Agreement to acquire Skylight Health Group Inc’s (NASDAQ:SLHG;TSXV:SLHG) medical cannabis certification businesses, Canna Care Docs and Relaxed Clarity. New Frontier Data plans to apply its comprehensive industry research, technology and consumer engagement capabilities to responsibly and transparently bring medical cannabis consumption and the growing medical cannabis patient community into focus.

“Access to vital medical cannabis data and the patient insights they represent has been greatly fragmented and difficult for the traditional medical establishment to embrace,” said New Frontier Data CEO Gary Allen. “Continuing our long-standing charge set by our founder (Giadha A. DeCarcer) to harness a diverse set of critical data sources, this acquisition will allow us to spotlight medical cannabis consumption trends for the constituents we serve today and will tomorrow.”

New Frontier Data will operate the newly acquired businesses under its new medical data division, CannaMedData. Cynthia Petrone-Hudock leads the new initiative as Interim CEO of CannaMedData.

“While now focused on people, process and technology stabilization and streamlining, this transition period should be short, allowing us to quickly turn our efforts toward growth and innovation, with the ultimate strategic goal to optimize and maximize capture of cannabis patient data,” said Petrone-Hudock. “This new and first-of-its-kind aggregate view of medical cannabis consumption enhances our data, research, and analytics, laying the foundation for mainstream medicine to embrace value-based medical cannabis care in the future.”

About New Frontier Data:

New Frontier Data is the premier data, analytics and technology firm specializing in the global cannabis industry, delivering solutions that enable investors, operators, advertisers, brands, researchers and policy makers to assess, understand, engage and transact with the cannabis industry and its consumers.

Our mission is to inform policy and commercial activity for the global legal cannabis industry. We maintain a neutral position on the merits of cannabis legalization through comprehensive and transparent data analysis and projections that shape industry trends, dynamics, demand and opportunity drivers. Founded in 2014, New Frontier Data is headquartered in Washington, D.C. with a presence in Europe, Latin America and Africa. For more information about New Frontier Data, please visit us at www.NewFrontierData.com.

CONTACT: Susan Clayton Hammann
New Frontier Data
+1 844-420-3882 ext. 3
media@newfrontierdata.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.